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E-mail address: mathias.gautel@kcl.ac.uk (M. GautNbr1, a ubiquitous kinase scaffold protein, contains a PB1, and a ubiquitin-associated (UBA) domain.
We show here that the nbr1 UBA domain binds to lysine-48 and -63 linked polyubiquitin-B chains.
Nbr1 also binds to the autophagic effector protein LC3-A via a novel binding site. Ubiquitin-binding,
but not PB1-mediated p62/SQSTM1 interaction, is required to target nbr1 to LC3 and polyubiquitin-
positive bodies. Nbr1 binds additionally to proteins implicated in ubiquitin-mediated protein turn-
over and vesicle trafﬁcking: ubiquitin-speciﬁc peptidases USP8, and the endosomal transport regu-
lator p14/Robld3. Nbr1 thus contributes to speciﬁc steps in protein turnover regulation disrupted in
several hereditary human diseases.
Structured summary:
MINT-7034452: USP8 (uniprotkb:P40818) physically interacts (MI:0218) with NBR1 (uniprotkb:Q14596)
by pull down (MI:0096)
MINT-7034438: SQSTM1 (uniprotkb:Q13501) and LC3 (uniprotkb:Q9H492) colocalize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
MINT-7034309: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with Ubiquitin (uni-
protkb:P62988) by pull down (MI:0096)
MINT-7034323: NBR1 (uniprotkb:P97432) physically interacts (MI:0218) with Ubiquitin (uni-
protkb:P62988) by pull down (MI:0096)
MINT-7034233: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with USP8 (uniprotkb:P40818)
by two hybrid (MI:0018)
MINT-7034207: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with Robld3 (uniprotkb:Q9JHS3)
by two hybrid (MI:0018)
MINT-7034400, MINT-7034418: NBR1 (uniprotkb:Q14596) and LC3 (uniprotkb:Q9H492) colocalize
(MI:0403) by ﬂuorescence microscopy (MI:0416)
MINT-7034167: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with Ubiquitin B (uni-
protkb:Q78XY9) by two hybrid (MI:0018)
MINT-7034470: NBR1 (uniprotkb:Q14596) and USP8 (uniprotkb:P40818) colocalize (MI:0403) by ﬂuores-
cence microscopy (MI:0416)
MINT-7034194: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with LC3-A (uniprotkb:Q91VR7)
by two hybrid (MI:0018)
MINT-7034336: SQSTM1 (uniprotkb:Q13501) physically interacts (MI:0218) with Ubiquitin (uni-
protkb:P62988) by pull down (MI:0096)
MINT-7034375: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with LC3 (uniprotkb:Q9H492)
by pull down (MI:0096)
MINT-7034350: NBR1 (uniprotkb:Q14596) and Ubiquitin (uniprotkb:P62988) colocalize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
MINT-7034181: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with Tmed10 (uni-
protkb:Q9D1D4) by two hybrid (MI:0018)
MINT-7034220: NBR1 (uniprotkb:Q14596) physically interacts (MI:0218) with ube2o (uniprotkb:Q6ZPJ3)
by two hybrid (MI:0018)
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Cellular protein turnover can use the ubiquitin–proteasome
system (UPS) or autophagy, two degradation pathways that share
the modiﬁcation of target proteins by small modiﬁer proteins in
sequential enzymatic cascades, and their subsequent sequestration
to speciﬁc degradation machineries. The UPS targets mostly solu-
ble, cytosolic proteins that are modiﬁed by ubiquitin and then re-
cruited to, and destroyed by, the proteasomal proteases.
Autophagy is the mechanism by which damaged organelles and
both soluble and aggregated proteins can be removed (reviewed
in [1,2]). The prerequisite of initial ‘‘labelling” of target proteins
by ubiquitin via speciﬁc ligases, their subsequent recognition by
adapter proteins, and the ensuing recruitment to the destruction
machinery in proteasomes and autophagosomes mediates certain
elements of speciﬁcity.
In autophagy, target proteins are recruited to and enveloped by
phagophore membrane structures containing the speciﬁc lipidated
ubiquitin-like protein ATG8/LC3 [3]. These then fuse with lyso-
somes to form autolysosomes, leading to the enzymatic destruc-
tion of their cargo. Autophagy is important for the continuous
ordered remodelling of tissues during postnatal development and
physiological adaptation, and not only during extreme conditions
like nutrient starvation [1].
One of the multifunctional adaptor proteins that link cellular
growth and survival signals to protein degradation via the protea-
some and autophagy is p62/SQSTM1 (also known as ORCA, lckBP,
A170 [4,5]) that has recently been implicated in regulating the
autophagy of ubiquitinated proteins [6] by its direct interaction
with LC3 [7–9]. p62/SQSTM1 interacts with, and shares many
structural features with the 107 kDa protein nbr1 [10], a protein
highly conserved between human (NBR1 gene) and mouse (Nbr1
gene). Both proteins contain an N-terminal p67phox/ Bem1p
(PB1) domain (also referred to as ubiquitin-like domain [5]), a ZZ
Zinc ﬁnger domain, and a C-terminal UBA domain (Fig. 1). Whereas
the type-A/B PB1 domain of p62/SQSTM1 allows the formation of
oligomeric complexes both with p62/SQSTM1 and other PB1 do-Fig. 1. Schematic layout of the domain organisation of nbr1 and p62/SQSTM1 and
the sites of protein–protein interactions; known nbr1 ligands are shown in grey.
The PB1 region was shown to bind p62/SQSTM1 and the open conformation of the
giant muscle protein kinase titin [13]; the middle segment binds fasciculation and
elongation protein zeta-1 (FEZ1), a PKCzeta interacting protein, and calcium and
integrin binding protein (CIB) [14]. The new nbr1 interactions described here are
shown in black. The extent of truncation constructs of nbr1 used for GST-binding
assays is shown. LC3 interactions are shown as + for positive and  for negative.
PB1, Phox/Bem1 homology 1 domain; ZZ, ZZ zinc ﬁnger domain; cc, coiled-coil
domain; UBA, ubiquitin associated domain.main proteins [4], nbr1 contains a type-A PB1 domain [11] and
only forms heterodimeric interactions through this motif; but
homodimerises via the N-terminal of two coiled-coil domains.
P62/SQSTM1 is currently the only known nbr1 PB1 ligand interact-
ing directly in a canonical PB1–PB1 fashion [12]. In addition, the
PB1 region of nbr1 also binds to the open catalytic site of the giant
muscle protein kinase titin [13]. Other links of nbr1 to protein ki-
nase signaling exist through the atypical PKC adaptor protein
FEZ1 [14] (Fig. 1). A mutation in human titin kinase that weakens
the nbr1 interaction leads to a severe hereditary myopathy, human
myopathy with early respiratory failure (HMERF) with disrupted
myoﬁbrils, localization of nbr1 to cytoplasmic bodies and accumu-
lation of p62/SQSTM1 with aggregated myoﬁbrillar proteins [13],
suggesting a defect in proteasomal or autophagic turnover. In con-
trast to p62/SQSTM1 however, very little is known about the li-
gands of nbr1 mediating the potential involvement in ubiquitin-
mediated protein turnover that might be inferred from its domain
pattern. To understand this ubiquitously expressed protein in bet-
ter detail, we performed interaction analysis in bone and muscle
yeast two-hybrid screens, and found generally expressed ligands
that link nbr1 to ubiquitin- and LC3-mediated protein turnover.2. Materials and methods
2.1. Nbr1 constructs and yeast two hybrid screening
Baits from the human NBR1 or the mouse Nbr1 gene were
ampliﬁed by PCR and cloned into the required vectors; the extent
of the constructs is shown in Fig. 1. Yeast two-hybrid screening
was essentially performed as described previously [15]. pLex were
co-transformed with a pGAD10 human cardiac muscle (Clontech)
or mouse calvarial bone cDNA library (a kind gift from Prof. Ikra-
muddin Aukhil, University of Florida) into the L40 yeast strain by
standard procedures. Transformants were screened by HIS3 repor-
ter gene activity, and selected clones were analysed for b-galacto-
sidase reporter gene activity.
2.2. GST pulldown assays
GST pulldown assays were essentially performed as described
[16]. COS7 cells were transfected with HA-tag or pEGFP-fusion
constructs and extracted with IP buffer (10 mM Tris–HCl (pH
7.9), 150 mM NaCl, 0.5% NP-40, 1 mM DTT supplemented with a
protease inhibitor cocktail (Roche)) and the cell lysates were incu-
bated with beads coupled with the appropriate GST fusion pro-
teins, or GST alone, for 2 h on ice. Following incubation, beads
were washed four times in IP buffer. The proteins retained on the
beads were separated on SDS–PAGE and then transferred on nitro-
cellulose membrane following standard procedures. Blots were
treated with mouse monoclonal anti-GFP or rat monoclonal anti-
HA tag (Roche) and subsequently with a secondary antibody
(HRP-conjugated anti-mouse or anti-rat (DAKO Cytomation, Glost-
rup, Denmark). Detection was performed by ECLTM Western blot-
ting analysis.
2.3. Ubiquitin binding assays
Two micrograms of GST fusion protein bound to glutathione
beads was incubated with 2 lg of K48 (Boston Biochem UC-230)
or K63 (Boston Biochem UC330) ubiquitin chains ranging from
two to seven and 400 ll IP buffer and were processed as above.
Samples were analysed by SDS–PAGE and Western blotting using
a rabbit polyclonal antibody against ubiquitin (Dako, Z0458).
Myc-tagged ubiquitin mutants used for cellular colocalisation
studies were a kind gift from Dr. Jo Morris, KCL.
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Human NBR1 (nbr1-A 486–903aa, nbr1-2 681–903 aa, nbr1-C
737–903 aa and nbr1-D 729–775 aa) and USP8 were cloned into
the pGST2C vector using the XhoI–BamHI sites and soluble pro-
teins were expressed in BL21[DE3] cells by standard protocols.
The fusion proteins were puriﬁed by glutathione afﬁnity chroma-
tography using standard procedures. The YFP-LC3 plasmid was a
kind gift by Dr. Marco Sandri. LC3 was expressed in fusion with a
His6-TEV site tag using a modiﬁed pET expression plasmid [17].
2.5. Cell culture, transfection and immunostaining
COS7 cells were cultured in DMEM/10% fetal bovine serum by
standard protocols and transfected using Fugene 6 (Roche). Cells
were lysed after 24 h in 500 ll IP buffer for pulldown assays, or
were ﬁxed with 4% paraformaldehyde in PBS for 6 min, then pro-
cessed for immunostaining as described [17]. All ﬂuorescent-con-
jugated secondary antibodies were purchased from Jackson
ImmunoResearch (USA) [18].
2.6. Primary antibodies
The following primary antibodies were used. Mouse monoclo-
nal anti-Nbr1 (Abcam, UK); mouse monoclonal anti-conjugated
ubiquitin FK2 (Biomol) and rabbit polyclonal anti-ubiquitin (Dako,
UK); rabbit polyclonal anti-LC3 (Cell Signaling Technology/New
England Biolabs, UK); rat monoclonal anti-HA tag (Roche); and rab-
bit polyclonal anti-Myc tag A14 (Santa Cruz).
2.7. Confocal microscopy and image analysis
Cell preparations were imaged with a Zeiss LSM510 confocal
microscope in sequential scanning mode, using a 63 oil immer-
sion objective and instrument zoom rates between 1 and 2.5.
3. Results
3.1. Multiple interactions link nbr1 to protein turnover regulation
For the identiﬁcation of new nbr1 ligands, yeast two-hybrid
screens with full-length nbr1, the nbr1 UBA domain, and two frag-
ments lacking both the PB1 and UBA domains (residues 93–903
and 495–924) were performed in mouse or human bone and mus-
cle cDNA libraries essentially as described [17]. Several hundred
HIS3 and b-galactosidase positive clones were isolated, and repor-
ter gene activation was tested to be bait-dependent. The inserts of
clones showing bait-dependent HIS3/b-GAL activation were se-
quenced and analysed. Here, we report only those clones that are
not tissue-speciﬁc; bone- and muscle-speciﬁc ligands will be de-
scribed elsewhere.
Most clones interacting with full-length or C-terminal nbr1 en-
coded ubiquitin-B (Table 1), but few ubiquitin A and C clones were
also identiﬁed. The interaction with ubiquitin was mapped by
truncation mutants to the UBA domain. Links to ubiquitin proteinTable 1
Ubiquitously expressed ligands of nbr1 identiﬁed in yeast two-hybrid screens from huma
Protein Accession
Ubiquitin-B NM_0116
LC3-A NM_0257
Ubiquitin-speciﬁc peptidase USP8 (UBPY) NM_0051
Ubiquitin conjugating enzyme E2O (Ube2o) NM_1737
p14, Robld3 NM_0312
Transmembrane enp24-like trafﬁcking protein 10 NM_0267modiﬁcation were also found by interactions with the ubiquitin
conjugating enzyme Ube2o, and ubiquitin-speciﬁc peptidase
USP8 (UBPY) (Table 1). Additionally, we identiﬁed microtubule
associated protein light chain-3 (LC3, the mammalian homologue
of yeast ATG8) as an nbr1 ligand. A link to vesicular trafﬁcking
was identiﬁed by the interaction with p14/Robld3 [19]) and trans-
membrane enp24-like trafﬁcking protein 10.
3.2. The nbr1 UBA domain binds both lysine-48 and lysine-63 linked
polyubiquitin chains
As the interaction of nbr1 with ubiquitin identiﬁed in living
yeast will be complemented by the yeast ubiquitination machin-
ery, and could be directed towards monoubiquitin or various poly-
ubiquitin chains, we characterised the nature of this interaction
using glutathione-S-transferase (GST) tagged proteins in vitro.
The GST-tagged nbr1 UBA domain was tested for its ability to inter-
act with lysine-48 and -63 (K48 or K63) linked polyubiquitin
chains in pulldown assays using synthetic polyubiquitin chains,
and compared to the binding properties of p62/SQSTM1 UBA. We
observed comparable binding to both types of ubiquitin chains
(Fig. 2A), although afﬁnity of p62/SQSTM1 for K63 linked chains
seems weaker. This ability to bind both common types of poly-
ubiquitin chains is shared with the structural homologue p62/
SQSTM1 [20], although the afﬁnity of nbr1 seems to be higher for
K63 chains in comparison to p62/SQSTM1, which in this assay fa-
vours K48-linked ubiquitin. In agreement with these in vitro data,
nbr1 colocalised in cytoplasmic bodies with conjugated ubiquitin
detected by the FK2 antibody (Fig. 2B), and with ubiquitin mutants
abolishing all but lysine-63 (Fig. 2B) and lysine-48 (not shown)
conjugation. However, colocalisation with a mutant ubiquitin abol-
ishing K63, K48 and K33 conjugation almost completely abolished
colocalisation of nbr1 in ubiquitin-positive bodies (Fig. 2B).
3.3. Nbr1 binds LC3 at a distinct site
The interaction with LC3 suggests an involvement of nbr1 in
autophagic protein turnover, similar to the structurally related
p62/SQSTM1. However, the recently identiﬁed LC3 binding site in
p62/SQSTM1 [7,21] shows no easily identiﬁed homology to nbr1.
We therefore created a series of GST-tagged truncation fragments
of nbr1, nbr1-A to nbr1-D (Fig. 1), to map the LC3 interaction in
pulldown binding assays using YFP-tagged LC3. These were also
tested with bacterially expressed LC3 to rule out the participation
of cellular factors in the pulldown assays. Nbr1 fragments lacking
the PB1, ZZ, coiled-coil-1 or UBA domains retained their ability to
interact with LC3 (Figs. 1 and 3A). Truncation of the coiled-coil do-
main 2 (aa 708–903) did not affect LC3 interaction (not shown),
while further truncation of an acidic-hydrophobic-rich segment
just C-terminal to coiled-coil 2 up to the ﬁrst proline residue after
the predicted helical coiled-coil 2 segment (nbr1-C) abolished LC3
binding. A 46-residue construct starting just at the end of coiled-
coil2 (nbr1-D, 729–775) bound strongly to LC3. The difference be-
tween the overlapping constructs nbr1-C and nbr1-D resides in the
eight amino acids SEDYIIIL, showing that these residues are crucialn muscle and mouse bone cDNA libraries.
number Clones Region
64.3 12 Full length
35.1 3 18–end
54 2 Full length
55.3 2 1164–1288
48.3 1 Full length
75.4 1 78–end
Fig. 2. Nbr1 binding to polyubiquitin chains. (A) GST-fused human (hNbr1) and mouse (mNbr1) UBA domains were immobilised on glutathione beads and incubated with
K48 and K63-linked polyubiquitin chains. An N-terminal fragment of human nbr1 without the UBA domain (hNbr1-2) and GST were used as negative controls; the UBA
domain of p62/SQSTM1 served as positive control. Bound ubiquitin was detected by Western blotting with anti-ubiquitin antibodies. (B) Transfected human nbr1 in COS7
cells colocalised with wild-type polyubiquitin chains detected by the FK2 monoclonal antibody, as well as with mutant ubiquitin in which all known lysine modiﬁcation sites
have been replaced by arginine except for K63 (myc-K63 only), while colocalisation with mutant ubiquitin in which lysines 33, 48 and 63 have been replaced with arginine
(myc-K63R, K48R and K33R) almost completely abolished colocalisation. Transfected nbr1 was detected via its N-terminal HA-tag, the mutant ubiquitins via their N-terminal
myc-tag. Scale bars: 10 lm.
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binding site in p62/SQSTM1 but lacks an obvious consensus se-
quence with p62/SQSTM1.
3.4. The UBA domain is necessary to recruit nbr1 to LC3-positive bodies
We assessed the localization of endogenous nbr1 and LC3 in
COS7 cells treated for 4 h with baﬁlomycin-A1, a speciﬁc cellular
inhibitor of vacuolar type H(+)-ATPase that inhibits the acidiﬁcat-
ion of organelles containing this enzyme and leads to accumulation
of unprocessed autophagosomes [22]. In baﬁlomycin-treated cells,
endogenous LC3 and nbr1 colocalise in cytoplasmic bodies,
whereas in untreated cells, both proteins are weakly stained and
sporadically colocalise (Fig. 3B). When we co-transfected HA-
tagged nbr1 with YFP-LC3 in COS7 cells, we observed nbr1 accu-
mulation in larger vesicle-like bodies that are very similar to those
observed for p62/SQSTM1 and LC3 (Fig. 3C). We suspected that
these reﬂect components of the autophagic pathway due to the
association with ubiquitin and LC3. Co-localization of nbr1 with
LC3 was independent of the presence of the PB1 domain that forms
the interface with p62/SQSTM1 [12,13], suggesting that nbr1 is not
indirectly recruited to LC3-positive bodies via p62/SQSTM1. In-
deed, p62/SQSTM1 and truncated nbr1 lacking the PB1 domain
both localize to cytoplasmic bodies but do not colocalise
(Fig. 3C), indicating that the ubiquitin and LC3-dependent target-
ing of nbr1 is independent of p62/SQSTM1 and vice versa. How-
ever, deletion of the UBA domain completely abrogated nbr1
recruitment to LC3 positive bodies, and both proteins were found
to be diffusely colocalised in the cytoplasm (Fig. 3C).3.5. Nbr1 and USP8/UBPY interact and colocalise
The nbr1 ligand ubiquitin-speciﬁc protease USP8/UBPY was ex-
pressed as a GST fusion protein and conﬁrmed for its ability to
interact with HA-tagged nbr1 in vitro (Fig. 4A), while we found that
an unrelated component of the ubiquitination machinery, UBE2E,
did not interact. As USP8 has been described as an endosomal ubiq-
uitin peptidase, we compared the cellular localization of nbr1 and
USP8 in COS7 cells. Under these conditions, we ﬁnd that transfec-
ted nbr1 and USP8 colocalise in cytoplasmic bodies (arrowheads in
Fig. 4B).
4. Discussion
We have identiﬁed a number of new ligands of nbr1 that links
this kinase scaffold to protein turnover via autophagy and prote-
asomal degradation. The nbr1 UBA domain binds to ubiquitin-B,
and more speciﬁcally to K48 and K63-linked polyubiquitin chains,
and thus behaves similar to the related p62/SQSTM1 [20]. How-
ever, the UBA domains of these two proteins are only 32% identical,
underscoring divergent ligand speciﬁcities that may also involve
ubiquitin-independent interactions like the interaction with
MuRF1/2 of p62/SQSTM1 [13]. This may explain why, despite over-
all similarity between both proteins, their intracellular trafﬁc
seems to be different, as shown by the distinct localization of
p62/SQSTM1 and the PB1-deleted form of nbr1 (Fig. 3C). It is note-
worthy that the afﬁnity of nbr1 for K63-linked polyubiquitin ap-
pears to be higher than that of p62/SQSTM1. Our results
demonstrate also that nbr1 is able to recruit ubiquitinated proteins
Fig. 3. Nbr1 interacts with LC3. (A) GST-fused human nbr1 constructs phased as in Fig. 1 were bound to glutathione beads and incubated with cell lysates from YFP-LC3
transfected COS7 cells or recombinant LC3. Upper panel: results for YFP-LC3. Lower panel: similar results were obtained using the same GST-nbr1 fragments (abbreviated as A
to D) and bacterially expressed His6-LC3, detected in Western blot by the LC3 monoclonal antibody (bound fractions shown only). i, input; u, unbound; b, bound fractions. (B)
Endogenous nbr1 and LC3 colocalise in COS7 cells treated for 4 h with baﬁlomycin-A (top panel), whereas levels are low when autophagic ﬂux is not inhibited (bottom panel).
(C) Colocalisation of transfected human nbr1 and LC3 in COS7 cells. LC3 colocalises in presumptive autophagosomes with the known ligand p62/SQSTM1, as well as with full-
length nbr1 (HA-nbr1) and with nbr1 lacking the PB1 domain (HA-nbr1DPB1). Deletion of the UBA domain (HA-nbr1DUBA) abolished the formation of LC3-positive bodies,
and both proteins were more diffusely colocalised in the cytoplasm. Deletion of the PB1 domain (HA-nbr1DPB1) allowed the formation of LC3 positive bodies but abrogated
the colocalisation with p62/SQSTM1. Scale bars: 10 lm.
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Fig. 4. Nbr1 interacts with USP8. (A) GST-fused human USP8 or UBE2E were bound to glutathione beads and incubated with cell lysates from HA-nbr1 transfected COS7 cells.
Nbr1 only interacts with USP8, not with the control proteins GST and UBE2E. i, input; u, unbound; b, bound fractions. (B) Colocalisation of human HA-tagged nbr1 and GFP-
tagged USP8 in cytoplasmic bodies of transfected COS7 cells. Arrowheads: colocalised nbr1 and USP8. Scale bar: 10 lm.
S. Waters et al. / FEBS Letters 583 (2009) 1846–1852 1851to LC3-positive bodies independently of p62/SQSTM1 and may
thus act redundantly to many of the latter’s functions. This possible
redundancy may have functional consequences when analysing
genetic defects or models of both proteins. For instance, it may ex-
plain why the mutations in the p62/SQSTM1 UBA domain that
cause Paget’s disease of the bone do not appear to elicit a more
generalised phenotype [23]. Furthermore, knockout animals of
p62/SQSTM1 have a tissue-restricted phenotype [9,24], arguing
again that some functions of p62/SQSTM1 can be taken over by
functionally analogous proteins like nbr1.
Overlapping functions of nbr1 and p62/SQSTM1 are also sug-
gested by their shared ability to bind to LC3 and polyubiquitin
simultaneously, thus presumably acting to recruit ubiquitinated
proteins to autophagosomes. The LC3 binding region of nbr1, how-
ever, shows no clear sequence homology to the structurally related
p62/SQSTM1. This sequence of ca. 8 residues is in a position N-ter-
minal to the UBA domain, an arrangement analogous to the LC3
binding site in p62/SQSTM1 (Fig. 1). However, sequence homology
in this region is low, although reminiscent of the LC3 binding site
in p62/SQSTM1. These results are in excellent agreement with
those published by Kirkin et al. [25] while this work was reviewed.
It is not clear whether the LC3 binding site in p62/SQSTM1 [7,8,21]
sufﬁces for autophagosome recruitment. Interestingly however,
LC3 interaction is insufﬁcient for nbr1 to induce formation of large
autophagosomes-like structures, which requires the presence of
the UBA domain (Fig. 3C). Although we show that LC3 can bind
to nbr1 constructs in the absence of coiled-coil 1 and 2, the dimeric
nature of nbr1 via its coiled-coil domains may be important to
cluster LC3-positive phagophore membranes around polyubiquiti-
nated target proteins during stages of autophagosomes maturation
[3]. The large bodies formed upon overexpression of nbr1, but also
of p62/SQSTM1, are obviously artifactual structures that suggest
that overexpression of nbr1 and p62 blocks the accurate processing
of autophagosomes. This effect may be useful to trap and identify
cellular targets for autophagosomal degradation delivered via
these adaptor proteins, which are expected to accumulate in the
LC3-positive bodies.
The interaction of nbr1 with the ubiquitin-speciﬁc peptidase
USP8/UBPY points further to a role of nbr1 in regulating the dy-
namic trafﬁc and fate of ubiquitinated proteins in endosomes, lyso-
somes and autophagosomes. USP8 can process K48- and K63-
linked polyubiquitin chains, and localizes to endosomes, which
accumulate ubiquitinated proteins [26,27]. The interaction with
nbr1, however, appears to be independent of polyubiquitin chains,and the function of nbr1 therefore seems to be that of a scaffold
that targets modulators of ubiquitin signalling to vesicular struc-
tures accumulating polyubiquitinated proteins at LC3-labelled
phagophores.
In summary, our results show that the protein kinase-associ-
ated scaffold protein nbr1 binds to several proteins implicated in
the trafﬁc of ubiquitinated proteins to lysosomes and autophago-
somes. Further links to vesicle trafﬁc were found (Table 1). Disrup-
tion of nbr1 function may therefore contribute to several human
diseases where protein turnover is defective. In muscle, a mutation
in the protein kinase domain of the nbr1 ligand titin abrogates
nbr1 binding and leads to a severe myopathy with early respiratory
failure [13]. Our results now implicate the failure of proper protein
homeostastis via autophagy and proteasomal turnover in the
mechanism of this disease, might explain the occurrence of nbr1-
positive vesicle-like bodies in the diseased muscles [13], and
would agree well with the increasingly recognised role of autoph-
agy in muscle mass regulation [28]. The link of both p62/SQSTM1
and nbr1 to ubiquitin-mediated autophagy also raises the interest-
ing possibility that nbr1 might be an unrecognised player in other
genetic conditions. p62/SQSTM1 is the most common gene mu-
tated in patients with Paget’s disease (reviewed in [23]). Similarly,
mutations in valosin-containing protein (VCP), which is involved in
ﬂux regulation of ubiquitinated proteins in proteasomes and lyso-
somes, cause a complex combination of myopathy, Paget’s disease
and frontotemporal dementia (reviewed in [29]). The partly over-
lapping functions of nbr1 and p62/SQSTM1 suggest that similar
functions in bone and muscle remodelling might be implicated in
defects leading to human bone and muscle disease. Physiological
studies of nbr1 function in speciﬁc tissues will now need to build
upon the generic nbr1 interactions identiﬁed here.
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